Involvement of GHRH signaling pathway in Ocular tumors

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037987

Enrollment

Unknown

Registered

2020-09-08

Start date

2021-05-01

Completion date

Unknown

Last updated

2020-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular tumors

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ocular tumor patients who need surgical treatment in Joint Shantou International Eye Center.

Exclusion criteria

Exclusion criteria: Patients who have been treated.

Design outcomes

Primary

Measure	Time frame
MTT cell activity;	—

Countries

China

Contacts

Public ContactLi Zeyi

JOINT SHANTOU INTERNATIONGAL EYE CENTER

lizeyi@jsiec.org+86 13413410133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026